Translational Development Acquisition Corp.
TDAC
$10.60
$0.000.00%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 944.50K | 915.60K | 763.20K | 543.80K | 197.20K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 944.50K | 915.60K | 763.20K | 543.80K | 197.20K |
| Operating Income | -944.50K | -915.60K | -763.20K | -543.80K | -197.20K |
| Income Before Tax | 6.36M | 4.76M | 3.04M | 1.41M | -71.80K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 6.36 | 4.76 | 3.04 | 1.41 | -0.07 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 6.36M | 4.76M | 3.04M | 1.41M | -71.80K |
| EBIT | -944.50K | -915.60K | -763.20K | -543.80K | -197.20K |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 0.29 | 0.22 | 0.13 | 0.05 | -0.02 |
| Normalized Basic EPS | 0.18 | 0.14 | 0.08 | 0.03 | -0.01 |
| EPS Diluted | 0.29 | 0.22 | 0.13 | 0.05 | -0.02 |
| Normalized Diluted EPS | 0.18 | 0.14 | 0.08 | 0.03 | -0.01 |
| Average Basic Shares Outstanding | 87.63M | 71.14M | 53.28M | 35.43M | 17.57M |
| Average Diluted Shares Outstanding | 87.63M | 71.14M | 53.28M | 35.43M | 17.57M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |